Skip to content Skip to footer
Hlth

2025 | HLTH Europe: 16-19 June | Amsterdam

HLTH Europe is the continent’s #1 healthcare innovation event. Following an enormously successful first event in 2024 and the exponential growth of HLTH in the US, this landmark event is where global expertise meets local insight to address Europe's unique healthcare challenges and opportunities.Don’t miss out on this opportunity to connect with like-minded individuals…

Read more

Pre-Conference Interviews ISPE Singapore Conference & Exhibition 2023

Pre-Conference Interviews: ISPE Singapore Conference & Exhibition 2023

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most renowned pharmaceutical manufacturing shows in Singapore for pharmaceutical and biomanufacturing professionals. The annual event highlights the best practices and services from manufacturing facility design to finished products.Click here to register now!We are thrilled to announce that we are taking the…

Read more

Thoughtspot_Mashum Mollah

Multichannel Marketing Tactics in Pharma: Harnessing the Power of Digital

In the dynamic landscape of the pharmaceutical industry, multichannel marketing has emerged as a powerful strategy to engage and connect with healthcare professionals, patients, and other stakeholders. This article explores the definition and importance of multichannel marketing in pharma, as well as the emerging opportunities it presents. With a focus on digital marketing, we delve into…

Read more

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

Event description: Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress-US Edition to be held on 28th June - 1st July 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers, and scientists from research institute pharmaceutical, bio-pharmaceutical, and biotechnology companies to discuss the latest updates in the development of ADC's,…

Read more

Insights+ Key Biosimilars Events of April 2020

Insights+ Key Biosimilars Events of April 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients. Hence, the providers are more likely to adopt biosimilars as a 'reference…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]